awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q58802587-6E22D166-2812-4442-A9ED-6D8A88295023
Q58802587-6E22D166-2812-4442-A9ED-6D8A88295023
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58802587-6E22D166-2812-4442-A9ED-6D8A88295023
Exploiting vulnerabilities in cancer signalling networks to combat targeted therapy resistance
P2860
Q58802587-6E22D166-2812-4442-A9ED-6D8A88295023
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58802587-6E22D166-2812-4442-A9ED-6D8A88295023
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4cde503d9ea8a6af30c241b9208616188eb072cd
P2860
Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia.